{"id":"https://openalex.org/W4282966495","doi":"https://doi.org/10.1158/1538-7445.am2022-6368","title":"Abstract 6368: Discovery of potent, orally bioavailable, SOS1 inhibitors for KRAS-driven tumors","display_name":"Abstract 6368: Discovery of potent, orally bioavailable, SOS1 inhibitors for KRAS-driven tumors","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282966495","doi":"https://doi.org/10.1158/1538-7445.am2022-6368"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-6368","doi":"https://doi.org/10.1158/1538-7445.am2022-6368","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6368","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059283198","display_name":"Sanjita Sasmal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjita Sasmal","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sukanya Patra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sukanya Patra","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067086651","display_name":"Venkatesham Boorgu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Venkatesham Boorgu","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085614415","display_name":"Mahesh Yanamadra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahesh Yanamadra","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045927477","display_name":"Ashok Ettam","orcid":"https://orcid.org/0009-0002-1205-8114","observed_orcids":["https://orcid.org/0009-0002-1205-8114"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashok Ettam","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018114822","display_name":"Nagaraju Dunaboyina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nagaraju Dunaboyina","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079309990","display_name":"Githavani Kummari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Githavani Kummari","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031700986","display_name":"Ram Mohan Yengala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ram Mohan Yengala","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069005201","display_name":"Balakrishna Lakhavath","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Balakrishna Lakhavath","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jayita Das","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayita Das","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011210304","display_name":"Satheesh Sunkanapally","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Satheesh Sunkanapally","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031458532","display_name":"Pravalika Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pravalika Reddy","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005049529","display_name":"Megha Mariam Mathew","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megha Mariam Mathew","raw_affiliation_strings":["1Satyarx Pharma Innovations Private Limited, Hyderabad, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Satyarx Pharma Innovations Private Limited, Hyderabad, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"6368","last_page":"6368"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.9721999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.008999999612569809,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sos1-inhibitor","display_name":"SOS1 inhibitor","score":0.9700000286102295},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.7680000066757202},{"id":"https://openalex.org/keywords/guanine-nucleotide-exchange-factor","display_name":"guanine nucleotide exchange factor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/kras-driven-tumors","display_name":"KRAS-driven tumors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7369999885559082},{"id":"https://openalex.org/keywords/mapk-inhibition","display_name":"MAPK inhibition","score":0.6589999794960022},{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.9179999828338623},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.8180000185966492},{"id":"https://openalex.org/keywords/akt-phosphorylation","display_name":"Akt phosphorylation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adme-properties","display_name":"ADME properties","score":0.7310000061988831},{"id":"https://openalex.org/keywords/antiproliferative-activity","display_name":"antiproliferative activity","score":0.8140000104904175}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9176235198974609},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5523812770843506},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5021488666534424},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4748288094997406},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.45675382018089294},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.45216265320777893},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.429370254278183},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3890860378742218},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35832762718200684},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.25874629616737366},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2338230311870575},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.19833457469940186},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13389137387275696},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07205867767333984}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-6368","doi":"https://doi.org/10.1158/1538-7445.am2022-6368","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-6368","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389239933","https://openalex.org/W4362594744","https://openalex.org/W4393072773","https://openalex.org/W2992279430","https://openalex.org/W4409627235","https://openalex.org/W4393072769","https://openalex.org/W4362593534","https://openalex.org/W7148624704","https://openalex.org/W4362596767","https://openalex.org/W4409820942"],"abstract_inverted_index":{"Abstract":[0],"KRAS":[1,17,19,92,118],"is":[2,26,39,115,124,149],"an":[3,44],"oncogene":[4],"implicated":[5],"in":[6,54,57,75,109,117,127,157],"a":[7,76,86,128],"wide":[8],"variety":[9],"of":[10,13,72,88,136,191,203],"tumors":[11,15,199],"(~21%":[12],"solid":[14],"harbor":[16],"mutations).":[18],"interaction":[20],"with":[21,31,98,133],"Guanidine":[22],"Exchange":[23],"Factors":[24],"(GEFs)":[25],"crucial":[27],"for":[28,47,155,197,207],"its":[29],"activation,":[30],"SOS1":[32,37,67,195],"being":[33],"the":[34,49,204],"predominant":[35],"GEF.":[36],"inhibition":[38],"thus":[40],"expected":[41],"to":[42],"be":[43],"effective":[45],"strategy":[46],"targeting":[48],"downstream":[50],"signaling":[51],"pathway,":[52],"resulting":[53],"anti-proliferative":[55,83],"activity":[56,74,84],"RAS-driven":[58],"cancers.":[59],"We":[60],"have":[61],"identified":[62],"multiple":[63],"potent":[64],"and":[65,90,95,113,139,148],"selective":[66],"inhibitors,":[68],"demonstrating":[69],"significant":[70,107],"reduction":[71,108,135],"GEF":[73],"dose-dependent":[77,134],"manner.":[78],"The":[79,141],"lead":[80,142],"compounds":[81],"show":[82],"across":[85],"panel":[87],"WT":[89],"mutant":[91,119],"cell":[93,120],"lines,":[94],"are":[96],"synergistic":[97],"MAPK":[99],"pathway":[100],"inhibitors":[101,196],"including":[102],"KRASG12C":[103],"inhibitor":[104],"Sotorasib.":[105],"Correspondingly,":[106],"PD":[110],"biomarkers,":[111],"pERK":[112,138],"pAKT":[114],"demonstrated":[116],"lines.":[121],"PK-PD":[122],"correlation":[123],"also":[125],"established":[126],"tumor":[129],"bearing":[130],"mice":[131],"model,":[132],"both":[137],"pAKT.":[140],"compound":[143],"shows":[144],"good":[145],"ADME":[146],"properties,":[147],"orally":[150,193],"bioavailable,":[151,194],"making":[152],"it":[153],"amenable":[154],"further":[156],"vivo":[158],"profiling.":[159],"Citation":[160],"Format:":[161],"Sanjita":[162],"Sasmal,":[163],"Sukanya":[164],"Patra,":[165],"Venkatesham":[166],"Boorgu,":[167],"Mahesh":[168],"Yanamadra,":[169],"Ashok":[170],"Ettam,":[171],"Nagaraju":[172],"Dunaboyina,":[173],"Githavani":[174],"Kummari,":[175],"Ram":[176],"Mohan":[177],"Yengala,":[178],"Balakrishna":[179],"Lakhavath,":[180],"Jayita":[181],"Das,":[182],"Satheesh":[183],"Sunkanapally,":[184],"Pravalika":[185],"Reddy,":[186],"Megha":[187],"Mariam":[188],"Mathew.":[189],"Discovery":[190],"potent,":[192],"KRAS-driven":[198],"[abstract].":[200],"In:":[201],"Proceedings":[202],"American":[205],"Association":[206],"Cancer":[208,219],"Research":[209],"Annual":[210],"Meeting":[211],"2022;":[212],"2022":[213],"Apr":[214],"8-13.":[215],"Philadelphia":[216],"(PA):":[217],"AACR;":[218],"Res":[220],"2022;82(12_Suppl):Abstract":[221],"nr":[222],"6368.":[223]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-06-17T00:00:00"}